|

MT-4561 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tanabe Pharma America, Inc.1

Indications

  • Nuclear Protein in Testis (NUT) Carcinoma1
  • Neuroendocrine Carcinoma (NEC)1
  • Neuroendocrine Tumor (NET)1
  • Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1

Los Angeles, California1 trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

University of Southern California

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.